Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Stryker Corporation
  6. Summary
    SYK   US8636671013

STRYKER CORPORATION

(SYK)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
12/01/2021 12/02/2021 12/03/2021 12/06/2021 12/07/2021 Date
239.1(c) 247.4(c) 246.87(c) 254.41(c) 259.7 Last
2 390 605 1 751 098 1 624 289 1 434 953 1 131 171 Volume
+1.04% +3.47% -0.21% +3.05% +2.08% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 17 062 M - -
Net income 2021 2 214 M - -
Net Debt 2021 9 233 M - -
P/E ratio 2021 44,0x
Yield 2021 0,99%
Sales 2022 18 349 M - -
Net income 2022 3 196 M - -
Net Debt 2022 7 083 M - -
P/E ratio 2022 30,4x
Yield 2022 1,08%
Capitalization 95 974 M 95 974 M -
EV / Sales 2021 6,17x
EV / Sales 2022 5,62x
Nbr of Employees 43 000
Free-Float 92,7%
More Financials
Company
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. Its segments include Orthopaedics, MedSurg, Neurotechnology and Spine. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical... 
Read more
More about the company
Ratings of Stryker Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about STRYKER CORPORATION
06:41aLoop Capital Starts Stryker at Buy With $305 Price Target
MT
12/06Stryker Corp. on Pace for Largest Percent Increase Since November 2020 -- Data Talk
DJ
12/03Global tax deal leaves billion-dollar loopholes, Reuters analysis finds
RE
11/19Stryker Management Outlines Long-Term Financial Guidance in Line With Pre-COVID Era Tar..
MT
11/19Morgan Stanley Adjusts Price Target on Stryker to $305 from $295, Keeps Overweight Rati..
MT
11/18STRYKER : Presentation (opens in new window)
PU
11/15INSIDER SELL : Stryker
MT
10/29STRYKER CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
10/29JPMorgan Adjusts Stryker's Price Target to $290 From $300, Maintains Overweight Rating
MT
10/29Piper Sandler Adjusts Stryker's Price Target to $250 From $255, Maintains Neutral Ratin..
MT
10/28Stryker Lowers Adjusted EPS Forecast
DJ
10/28Stryker Q3 Adjusted Earnings, Revenue Rise; Full-Year Adjusted EPS Guidance Lowered
MT
10/28STRYKER : Q3 Earnings Snapshot
AQ
10/28STRYKER REPORTS THIRD QUARTER 2021 OPERATING RESULTS - Form 8-K
PU
10/28Earnings Flash (SYK) STRYKER CORPORATION Reports Q3 Revenue $4.16B, vs. Street Est of $..
MT
More news
News in other languages on STRYKER CORPORATION
11/19La direction de Stryker présente des prévisions financières à long terme conformes aux ..
11/15VENTE PAR UN INITIÉ : Stryker
10/28STRYKER : hausse du bénéfice ajusté et du chiffre d'affaires au troisième trimestre, abais..
10/28Earnings Flash (SYK) STRYKER CORPORATION annonce un chiffre d'affaires de 4,16 milliard..
10/28Stryker Corporation fournit des prévisions de résultats pour l'année 2021
More news
Analyst Recommendations on STRYKER CORPORATION
More recommendations
Analysis
Global tax deal leaves billion-dollar loopholes, Reuters analysis finds
Chart STRYKER CORPORATION
Duration : Period :
Stryker Corporation Technical Analysis Chart | SYK | US8636671013 | MarketScreener
Technical analysis trends STRYKER CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Last Close Price 254,41 $
Average target price 284,41 $
Spread / Average Target 11,8%
EPS Revisions
Managers and Directors
Kevin A. Lobo Chairman, President & Chief Executive Officer
Timothy J. Scannell Executive Advisor
Glenn S. Boehnlein Chief Financial Officer & Vice President
Alan Douville Chief Information Officer & Vice President
Dana S. McMahon Chief Compliance Officer & Vice President
Sector and Competitors
1st jan.Capi. (M$)
STRYKER CORPORATION3.82%95 974
SMITH & NEPHEW PLC-16.36%14 703
INSPIRE MEDICAL SYSTEMS, INC.12.98%5 814
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.-2.97%2 794
AXONICS, INC.9.88%2 539
GLAUKOS CORPORATION-44.92%1 942